These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 20555240)
1. Overcoming barriers to new treatment options for hepatitis C. Brennan CS Nurse Pract; 2010 Jul; 35(7):20-9; quiz 29-30. PubMed ID: 20555240 [No Abstract] [Full Text] [Related]
2. Hepatitis C. Understanding the issues. Miller SK Adv Nurse Pract; 2000 Dec; 8(12):49-50, 87-8. PubMed ID: 12397910 [No Abstract] [Full Text] [Related]
3. Hepatitis C in children. Sehgal S; Jackson Allen PL Pediatr Nurs; 2004; 30(5):409-13. PubMed ID: 15587536 [No Abstract] [Full Text] [Related]
4. New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. Farrell GC J Gastroenterol Hepatol; 2007 May; 22(5):607-10. PubMed ID: 17444844 [No Abstract] [Full Text] [Related]
5. Hepatitis C identification and management by family physicians. Clark EC; Yawn BP; Galliher JM; Temte JL; Hickner J Fam Med; 2005 Oct; 37(9):644-9. PubMed ID: 16193428 [TBL] [Abstract][Full Text] [Related]
6. Overcoming barriers to care for hepatitis C. Clark PJ; Muir AJ N Engl J Med; 2012 Jun; 366(26):2436-8. PubMed ID: 22738095 [No Abstract] [Full Text] [Related]
7. Make each patient count. Berry JA; Coverston CR; Williams M Nurse Pract; 2008 Feb; 33(2):42-7. PubMed ID: 18300791 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C and HIV: ribavirin plus interferon study recruiting. AIDS Treat News; 1998 May; (No 295):5. PubMed ID: 11365407 [TBL] [Abstract][Full Text] [Related]
10. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen. Koff RS Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723 [No Abstract] [Full Text] [Related]
11. Hepatitis C virus. Jarrett M; Cox P Nurs Clin North Am; 2004 Mar; 39(1):219-29. PubMed ID: 15062738 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover. Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119 [TBL] [Abstract][Full Text] [Related]
14. Therapy of hepatitis C: alpha interferon and ribavirin. Reichard O; Schvarcz R; Weiland O Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674 [TBL] [Abstract][Full Text] [Related]
15. Management of hepatitis B virus infection. Lee H; Park W; Yang JH; You KS Gastroenterol Nurs; 2010; 33(2):120-6; quiz 127-8. PubMed ID: 20389225 [TBL] [Abstract][Full Text] [Related]
17. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Wiesner RH; Sorrell M; Villamil F; Liver Transpl; 2003 Nov; 9(11):S1-9. PubMed ID: 14586888 [No Abstract] [Full Text] [Related]
19. Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James. Dieterich D AIDS Treat News; 1998 May; (No 295):1-5. PubMed ID: 11365406 [TBL] [Abstract][Full Text] [Related]
20. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation. Fontana M; Ciuffreda D; Moradpour D; Pascual M Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091 [No Abstract] [Full Text] [Related] [Next] [New Search]